Measurement of C-reative protein in adults with febrile neutropenia after hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 33, Issue 7, 2004, Pages 741-744

  Ortega, M ^a   Rovira, M ^a   Almela, M ^a   de la Bellacasa, J P ^a   Carreras, E ^a   Mensa, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

C reactive protein; Febrile neutropenic adult; Hematopoietic cell transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; BUSULFAN; C REACTIVE PROTEIN; CARMUSTINE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; PENTAMIDINE; ANTIINFECTIVE AGENT;

ACUTE LEUKEMIA; ADULT; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FATALITY; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PATIENT MONITORING; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; WHOLE BODY RADIATION; BLOOD; FEVER; INFECTION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NEUTROPENIA; PREDICTION AND FORECASTING;

ADULT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFECTION; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 3442898259     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704409     Document Type: Article

References (9)

1. Claus DR, Osmand AP, Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976; 87: 120-128.
2. Peltola H, Holmberg C. Rapidity of C-reactive protein in detecting potential septicemia. Pediatr Infect Dis 1983; 2: 374-376.
3. Wasunna A, Whitelaw A, Gallimore R et al. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr 1990; 149: 424-427.
4. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982; 389: 406-418.
5. Santolaya ME, Cofre J, Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 1994; 18: 589-595.
6. Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114-121.
7. Schots R, Kaufman L, Van Riet I et al. Monitoring of C-reactive protein after allogenic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant 1998; 22: 79-85.
8. Schots R, Van Riet I, Ben Othman T et al. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 441-446.
9. Grützmeier S, von Schenck H. C-reactive protein during chemotherapy for acute leukemia with special reference to non-infective causes of fever. Med Oncol Tumor Pharmacother 1986; 3: 71-75.